Two Sigma Securities, LLC Immuno Gen, Inc. Transaction History

Two Sigma Securities, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$2.12 - $6.8 $56,881 - $182,450	-26,831 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$2.25 - $5.8 $60,369 - $155,619	26,831 New	26,831 $137,000
Q3 2019 Nov 14, 2019	SELL	$2.22 - $3.39 $26,742 - $40,835	-12,046 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$1.8 - $3.3 $13,273 - $24,334	-7,374 Reduced 37.97%	12,046 $26,000
Q1 2019 May 15, 2019	BUY	$2.41 - $5.91 $46,802 - $114,772	19,420 New	19,420 $53,000
Q4 2017 Feb 14, 2018	SELL	$5.07 - $7.92 $153,565 - $239,888	-30,289 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$5.4 - $8.47 $163,560 - $256,547	30,289	30,289 $232,000

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.